M Ellis Selected Research

M Ellis Research Topics

Disease

6	Neoplasms (Cancer) 04/2016 - 06/2000
3	Breast Neoplasms (Breast Cancer) 08/2002 - 11/2001
2	Thrombosis (Thrombus) 09/2011 - 05/2000
2	Infections 10/2006 - 10/2002
2	Endocarditis 02/2003 - 10/2002
2	Invasive Pulmonary Aspergillosis 05/2002 - 06/2000
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2021
1	Metatarsalgia 06/2020
1	Ovarian Neoplasms (Ovarian Cancer) 04/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2012
1	Venous Insufficiency 12/2011
1	Multiple Sclerosis 09/2011
1	Aneurysm (Aneurysms) 11/2009
1	Hemorrhage 08/2007
1	Varicose Ulcer (Ulcer, Venous) 04/2007
1	Chemotherapy-Induced Febrile Neutropenia 10/2006
1	Lymphoma (Lymphomas) 10/2006
1	Febrile Neutropenia 10/2006
1	Neutropenia 10/2006
1	Hematoma 04/2006
1	Candidiasis (Moniliasis) 06/2004
1	Septic Shock (Toxic Shock Syndrome) 02/2003
1	Ischemia 12/2002
1	Peritonitis 10/2002
1	Urinary Tract Infections (Urinary Tract Infection) 10/2002
1	Fungemia 10/2002
1	Endophthalmitis (Ophthalmia) 10/2002
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2002
1	Fever (Fevers) 05/2002
1	Hematologic Neoplasms (Hematological Malignancy) 05/2002
1	Aspergillosis 01/2002
1	Migraine without Aura (Common Migraine) 03/2001
1	Necrosis 03/2001
1	Leukemia 03/2001
1	Migraine with Aura (Familial Hemiplegic Migraine) 03/2001
1	Thrombophilia 03/2001
1	Myocardial Infarction 01/2001
1	Critical Illness (Critically Ill) 06/2000
1	Invasive Fungal Infections 06/2000
1	Brain Diseases (Brain Disorder) 05/2000
1	Thyroid Diseases (Thyroid Disease) 05/2000
1	Necrotizing Fasciitis 05/2000

Drug/Important Bio-Agent (IBA)

3	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2002 - 06/2000
3	liposomal amphotericin B FDA Link 05/2002 - 06/2000
2	Tamoxifen FDA LinkGeneric 08/2002 - 11/2001
2	LipidsIBA 03/2001 - 06/2000
1	CalpainIBA 01/2021
1	Hormones (Hormone)IBA 04/2016
1	AnnexinsIBA 04/2016
1	IntegrinsIBA 04/2016
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2016
1	ThyroninesIBA 04/2016
1	Thyroid HormonesIBA 04/2016
1	R-CHOP protocolIBA 11/2015
1	Complement System Proteins (Complement)IBA 05/2012
1	mesoglycanIBA 12/2011
1	Pharmaceutical PreparationsIBA 03/2009
1	Antineoplastic Agents (Antineoplastics)IBA 03/2009
1	Biological ProductsIBA 03/2009
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2006
1	AnticoagulantsIBA 04/2006
1	Itraconazole (Sporanox)FDA LinkGeneric 06/2004
1	Fluconazole (Zonal)FDA LinkGeneric 06/2004
1	Staphylococcal enterotoxin AIBA 02/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2002
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2002
1	Fulvestrant (Faslodex)FDA Link 08/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2002
1	CytokinesIBA 01/2002
1	Letrozole (Femara)FDA LinkGeneric 11/2001
1	Thrombin FDA Link 03/2001
1	Prothrombin (Factor II)IBA 03/2001
1	Indicators and Reagents (Reagents)IBA 03/2001
1	LeptinIBA 01/2001
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2001
1	Antifungal AgentsIBA 06/2000
1	Oxytocin (Pitocin)FDA LinkGeneric 05/2000
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2000
1	EpitopesIBA 05/2000
1	AntibodiesIBA 05/2000
1	Antiphospholipid AntibodiesIBA 05/2000
1	Oxygen (Dioxygen)IBA 05/2000
1	AutoantibodiesIBA 05/2000

Therapy/Procedure

9	Therapeutics 03/2009 - 11/2001
2	Drug Therapy (Chemotherapy) 10/2006 - 05/2002
1	Osteotomy 06/2020
1	Conservative Treatment 06/2020
1	Thrombectomy 09/2011
1	Stents 11/2009
1	Biological Therapy 03/2009
1	Bandages (Bandage) 04/2007
1	Drug Tapering 10/2006
1	Embolectomy 12/2002
1	Fasciotomy 12/2002
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 10/2002